Posted on 3月 17, 20233/17/23
Successfully Navigating Self-Commercialisation in Europe
Posted on 3月 15, 20233/15/23
Successful Launches in Europe: Complex, but Not Complicated?
Posted on 3月 1, 20233/1/23
The Future of Pharma – A Provocative Perspective
Posted on 2月 22, 20232/22/23
Bringing a CPT Code to Life to Help in the Fight Against Cancer
Posted on 2月 21, 20232/21/23
Critical Success Factors for Launching Products with Orphan Drug Designation
Posted on 11月 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on 11月 13, 202211/13/22
Establishing the Patient Access Mission During Clinical Development
Posted on 11月 10, 202211/10/22
Maximize In-Licensing Growth
Posted on 10月 24, 202210/24/22
David and Goliath: How Can First-Time Launchers Avoid Failure and Beat Big Pharma Launches
Posted on 10月 17, 202210/17/22